DE1067033B - Process for the preparation of basic substituted monoethers of 2-methyl 5 8-dioxy-4'5 6,7-furano chromons - Google Patents
Process for the preparation of basic substituted monoethers of 2-methyl 5 8-dioxy-4'5 6,7-furano chromonsInfo
- Publication number
- DE1067033B DE1067033B DENDAT1067033D DE1067033DA DE1067033B DE 1067033 B DE1067033 B DE 1067033B DE NDAT1067033 D DENDAT1067033 D DE NDAT1067033D DE 1067033D A DE1067033D A DE 1067033DA DE 1067033 B DE1067033 B DE 1067033B
- Authority
- DE
- Germany
- Prior art keywords
- dioxy
- methyl
- preparation
- basic substituted
- chromons
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 3
- SYRKLPUYGHMXDN-UHFFFAOYSA-N 2-methylquinoline-5,8-dione Chemical compound O=C1C=CC(=O)C2=NC(C)=CC=C21 SYRKLPUYGHMXDN-UHFFFAOYSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 229940027983 antiseptics and disinfectants Quaternary ammonium compounds Drugs 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 150000003856 quaternary ammonium compounds Chemical class 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims description 2
- 150000001350 alkyl halides Chemical class 0.000 claims description 2
- 125000004432 carbon atoms Chemical group C* 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N propylene oxide Chemical class CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 claims description 2
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000000243 solution Substances 0.000 description 5
- HSMPDPBYAYSOBC-UHFFFAOYSA-N Khellin Chemical compound O1C(C)=CC(=O)C2=C1C(OC)=C1OC=CC1=C2OC HSMPDPBYAYSOBC-UHFFFAOYSA-N 0.000 description 4
- 229960002801 Khellin Drugs 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 4
- POLCUAVZOMRGSN-UHFFFAOYSA-N Dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 3
- -1 1-diethylaminopropane epoxide Chemical class 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 125000003700 epoxy group Chemical group 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 150000003840 hydrochlorides Chemical class 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 230000002588 toxic Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- CPBZARXQRZTYGI-UHFFFAOYSA-N 3-cyclopentylpropylcyclohexane Chemical compound C1CCCCC1CCCC1CCCC1 CPBZARXQRZTYGI-UHFFFAOYSA-N 0.000 description 1
- 210000004351 Coronary Vessels Anatomy 0.000 description 1
- YGKXCLZSNFVFQR-UHFFFAOYSA-N N-butyl-N-(oxiran-2-ylmethyl)butan-1-amine Chemical compound CCCCN(CCCC)CC1CO1 YGKXCLZSNFVFQR-UHFFFAOYSA-N 0.000 description 1
- 150000003973 alkyl amines Chemical group 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000005591 charge neutralization Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 150000002829 nitrogen Chemical group 0.000 description 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000001187 sodium carbonate Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000002048 spasmolytic Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
DEUTSCHESGERMAN
In der Deutschen Patentschrift 924 693 werden basisch substituierte Monoäther des 2-Methyl-5,8-dioxy-4',5': 6,7-furanochromons beschrieben, die eine der Wirkung des Khellins sehr ähnliche therapeutische Wirkung zeigen, weniger toxisch sind als das KheUin und — im Gegensatz zu dem im Wasser nur schwer lösüchen Khellin — zumindest in Form ihrer Salze oder quartären Ammoniumverbindungen leicht wasserlöslich und infolgedessen für Injektionszwecke gut geeignet sind. 'In German Patent 924 693, basic substituted monoethers of 2-methyl-5,8-dioxy-4 ', 5': 6,7-furanochromone are used described the therapeutic effect very similar to the effect of khellin show are less toxic than the KheUin and - im In contrast to khellin, which is difficult to dissolve in water - at least in the form of its salts or quaternary Ammonium compounds are easily soluble in water and are therefore well suited for injection purposes. '
Die Herstellung dieser bekannten therapeutisch wirksamen basischen Äther erfolgt durch Umsetzen des 2-Methyl-5,8-dioxy-4',5': 6,7-furanochromons mit einem Halogenid eines niederen tertiären Alkylamins, gegebenenfalls in Form seines Hydrohalogenids.These known therapeutically effective basic ethers are produced by converting the 2-methyl-5,8-dioxy-4 ', 5': 6,7-furanochromons with a halide of a lower tertiary alkylamine, optionally in the form of its hydrohalide.
Es wurde gefunden, daß man überraschenderweise sehr leicht zu ähnlichen basischen Monoäthern mit betonter khellinähnlicher Wirkung kommt, wenn man 2-Methyl-S,8-dioxy-4',5':6,7-furanochromon — im folgenden als Khellinchinol bezeichnet — mit basisch substituierten : Pröpylenoxyden der allgemeinen FormelIt has been found that, surprisingly, it is very easy to obtain similar basic monoethers with pronounced khellin-like action if 2-methyl-S, 8-dioxy-4 ', 5': 6,7-furanochromone - hereinafter referred to as khellinquinol - is used Basically substituted : propylene oxides of the general formula
zur Herstellung basisch substituierterfor the production of basic substituted
Monoäther des 2-Methyl-5,8-dioxy-Monoether of 2-methyl-5,8-dioxy-
4',5': 6,7-furanochromons4 ', 5': 6,7-furanochromons
Anmelder:Applicant:
Chem. pharmaz. FabrikChem. Pharmaz. factory
Dr. Hermann Thiemann G.m.b.H.,Dr. Hermann Thiemann G.m.b.H.,
Lünen (Westf.), Kirchstr. 12Lünen (Westphalia), Kirchstr. 12th
Dr. Helmuth Schäfer, Hamburg-Fuhlsbüttel,
ist als Erfinder genannt worden .Dr. Helmuth Schäfer, Hamburg-Fuhlsbüttel,
has been named as the inventor.
umsetzt, in der R1 und R2 niedere Alkylreste mit 1 bis 4 Kohlenstoffatomen oder zusammen mit dem Stickstoffatom einen gesättigten heterocyclischen Ring, insbesondere einen Piperidin- oder Morpholinring, darstellen.reacted, in which R 1 and R 2 represent lower alkyl radicals with 1 to 4 carbon atoms or together with the nitrogen atom a saturated heterocyclic ring, in particular a piperidine or morpholine ring.
Das basische Eppxyd lagert sich ohne Verwendung ..... weiterer Hilfsmittel unter Aufsprengung des Epoxydringes an die in 8-Steüung befindliche ÖH-Gruppe des1 Khellinchinols an.The basic epoxy accumulates without the use of ..... further aids and the epoxy ring bursts onto the 8-position ÖH group of the 1 khellinquinol.
Die Reaktion, die in einem geeigneten organischen Lösungsmittel und zweckmäßigerweise in inerter Gasatmosphäre durchgeführt wird, verläuft nach folgender Gleichung:The reaction, which takes place in a suitable organic solvent and conveniently in an inert gas atmosphere is carried out according to the following equation:
CH3 + ;N —CH2-CH-CH2 CH 3 +; N -CH 2 -CH-CH 2
OH OOH O
CH2-CH-CH2-N;
OHCH 2 -CH-CH 2 -N;
OH
Die auf diese Weise erhaltenen basischen Khellinchinoläther können in an sich bekannter Weise mit Säuren zu Salzen oder mit Alkylhalogeniden zu quartären Ammoniumverbindungen umgesetzt werden.The basic khellinquinol ethers obtained in this way can be used in a manner known per se Acids are converted to salts or with alkyl halides to form quaternary ammonium compounds.
Die sekundäre OH-Gruppe in der Seitenkette der erfindungsgemäß hergestellten Verbindungen bietet einen guten Ansatzpunkt für weitere Synthesen bzw. Substitutionen. Sie kann beispielsweise veräthert oder verestert werden.The secondary OH group in the side chain of the compounds prepared according to the invention offers one good starting point for further syntheses or substitutions. For example, it can be etherified or esterified will.
Die nach dem beschriebenen Verfahren hergestellten Verbindungen wirken in gleicher Weise wie Khellin spasmolytisch und erweiternd auf die Coronargef äße; sie sind aber wesentlich weniger toxisch als Khellin und in Form ihrer Salze sehr gut wasserlöslich. Ihre SalzeThe compounds produced by the process described act in the same way as khellin spasmolytic and expanding on the coronary vessels; however, they are much less toxic than khellin and, in the form of their salts, are very soluble in water. Your salts
.909 638/377.909 638/377
1515th
können außerdem als Lösungsvermittler für KheUin Verwendung finden.can also be used as solubilizers for KheUin.
Kheliinchinol-8-(7-diäthylamino-|S-oxy)-propylätherKheliinquinol-8- (7-diethylamino- | S-oxy) propyl ether
23,2 g KheUinchinol werden in 150 ecm Äthanol unter Rühren und Durchleiten von Stickstoff zum Sieden erhitzt. Ina Verlaufe von 1 Stunde werden 15,5 g 1-Diäthylaminopropanepoxyd-(2,3) zugetropft. Das Reaktionsgemisch wird danach noch 3 Stunden am Rückfluß gekocht, wobei das KheUinchinol langsam in Lösung geht. Mit etwa 12 ecm konz. Salzsäure wird schwach angesäuert und im Vakuum zur Trockene eingedampft. Der Rückstand wird mit 150 ecm Wasser aufgenommen, vom Unlöslichen abfiltriert und aus dem Filtrat durch Zugabe von 10 %iger Sodalösung die Rohbase gefäUt. Diese wird in Benzol aufgenommen, das Benzol im Vakuum abdestilliert und der dunkle Rückstand aus Cyclohexan umkristallisiert. Man erhält.so in guter Ausbeute den KheUinchinol-8-(ydiäthylamino-/S-oxy)-pröpyläther in Form gelber Kristalle ao vom F. 990C. ; 23.2 g of KheUinchinol are heated to boiling in 150 ecm of ethanol while stirring and passing nitrogen through. 15.5 g of 1-diethylaminopropane epoxide (2,3) are added dropwise over the course of 1 hour. The reaction mixture is then refluxed for a further 3 hours, the KheUinchinol slowly going into solution. With about 12 ecm conc. Hydrochloric acid is weakly acidified and evaporated to dryness in vacuo. The residue is taken up with 150 ecm of water, the insolubles are filtered off and the crude base is removed from the filtrate by adding 10% sodium carbonate solution. This is taken up in benzene, the benzene is distilled off in vacuo and the dark residue is recrystallized from cyclohexane. One erhält.so in good yield the KheUinchinol-8- (ydiäthylamino- / S-oxy) -pröpyläther in the form of yellow crystals, melting at 99 0 C. ao;
Aus dieser Base erhält man, indem man sie in der 5fachen Menge absolutem Alkohol löst und dann mit gasförmiger Salzsäure neutralisiert, das Hydrochlorid in Form gelblicher Kristalle vom F. 198 bis 199° C.This base is obtained by dissolving it in 5 times the amount of absolute alcohol and then using it gaseous hydrochloric acid neutralized, the hydrochloride in the form of yellowish crystals from 198 to 199 ° C.
Das Hydrochlorid löst sich zu einem Gewichtsteil in 1,5 Gewichtsteilen Wasser von 20° C und ergibt eine 40 °/oige Lösung. .One part by weight of the hydrochloride dissolves in 1.5 parts by weight of water at 20 ° C. and gives a 40% solution. .
Beispiel 2
KheUinchinol-8-(y-piperidino-^-oxy)-propylätherExample 2
KheUinchinol-8- (γ-piperidino - ^ - oxy) -propylether
Man arbeitet wie im Beispiel!, ersetzt aber das 1-Diäthylamino-propanepoxyd-(2,3) durch 16,9 g 1-Piperidino-propanepoxyd-(2,3). Aus dem wie im Beispiel 1 anfallenden Rohprodukt erhält man durch Umkristallisation aus Cyclohexan den Khellinchinol-8-(y-piperidino-jS-oxy)-propyläther in Form gelber Kristalle vom F. 124° C.You work as in the example !, but replaces the 1-diethylamino-propane epoxide (2,3) by 16.9 g of 1-piperidino-propane-epoxide (2,3). From the resulting as in Example 1 The crude product is obtained by recrystallization from cyclohexane, the khellinquinol-8- (γ-piperidino-jS-oxy) propyl ether in the form of yellow crystals with a temperature of 124 ° C.
In Äthanol gelöst, fäUt nach Neutralisation mit äthanolischer Salzsäure das Hydrochlorid dieser Base vom F. 223 bis 224° C aus.Dissolved in ethanol, fouls after neutralization with ethanol Hydrochloric acid, the hydrochloride of this base with a temperature of 223 to 224 ° C.
Dieses Hydrochlorid löst sich zu einem Gewichtsteil in Gewichtsteüen Wasser von 20° C, was eine 23°/0ige Lösung ergibt.This hydrochloride dissolves to one part by weight in Gewichtsteüen water at 20 ° C, giving a 23 ° / 0 resulting solution.
' Beispiel 3 ''Example 3'
Khellinchinol-8- (y-dibutylamino-/S-oxy) -propylätherKhellinquinol 8- (y-dibutylamino / S-oxy) propyl ether
Wie im Beispiel 1 angegeben, setzt man 11,6 g KheUinchinol in 80 ecm Methanol mit 10,5 g 1-Dibutylamino-2,3-epoxypropan in 10 ecm Methanol um. Man erhält den ίο basischen Äther durch Umkristallisieren aus Cyclohexan in Form gelber Kristalle vom F. 89 bis 90° C. Zur DarsteUung des Hydrochloride wird die Base in Äthanol gelöst und mit gasförmiger Salzsäure neutralisiert. Das Hydrochlorid kristallisiert in blaßgelben Kristallen vom F. 202 bis 203° C.As indicated in Example 1, 11.6 g of khequinol are added to 80 ecm of methanol with 10.5 g of 1-dibutylamino-2,3-epoxypropane in 10 ecm of methanol. The basic ether is obtained by recrystallization from cyclohexane in the form of yellow crystals with a temperature of 89 to 90 ° C. To represent the hydrochloride, the base is dissolved in ethanol dissolved and neutralized with gaseous hydrochloric acid. The hydrochloride crystallizes in pale yellow crystals from F. 202 to 203 ° C.
Dieses Hydrochlorid löst sich mit einem Teil in 6 Teilen Wasser von 20°C, was eine l^o/qige Lösung ergibt.One part of this hydrochloride dissolves in 6 parts Water at 20 ° C, which results in a 10% solution.
Claims (1)
Publications (1)
Publication Number | Publication Date |
---|---|
DE1067033B true DE1067033B (en) | 1959-10-15 |
Family
ID=593010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DENDAT1067033D Pending DE1067033B (en) | Process for the preparation of basic substituted monoethers of 2-methyl 5 8-dioxy-4'5 6,7-furano chromons |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE1067033B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2077694A1 (en) * | 1970-02-06 | 1971-11-05 | Sobio Lab | Isopropylaminopropyl ethers of khellin-quinol - as coronary vasodilat and oxygen economisers |
FR2232311A1 (en) * | 1973-06-05 | 1975-01-03 | Sobio Lab | Antiarrhythmic khellin-quinol derivs. - comprising the t-butyl-amino-hydroxy-propyl and di-isopropyl-amino-ethyl ethers |
-
0
- DE DENDAT1067033D patent/DE1067033B/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2077694A1 (en) * | 1970-02-06 | 1971-11-05 | Sobio Lab | Isopropylaminopropyl ethers of khellin-quinol - as coronary vasodilat and oxygen economisers |
FR2232311A1 (en) * | 1973-06-05 | 1975-01-03 | Sobio Lab | Antiarrhythmic khellin-quinol derivs. - comprising the t-butyl-amino-hydroxy-propyl and di-isopropyl-amino-ethyl ethers |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2157424B2 (en) | Therapeutically effective N, N'disubstituted cyclic diamines and processes for their preparation | |
DE1067033B (en) | Process for the preparation of basic substituted monoethers of 2-methyl 5 8-dioxy-4'5 6,7-furano chromons | |
DE2609015A1 (en) | PROCESS FOR THE PREPARATION OF BENZ (F) -2,5-OXAZOCINES | |
DE2166270C3 (en) | Nicotinoylaminoethanesulfonyl-2amino-thiazole | |
DE2462967C2 (en) | Derivatives of 3-amino-5-methyl-2-phenyl-pyrrole, their salts and pharmaceutical preparations containing them | |
DE948979C (en) | Process for the production of anticholinergic salts of quaternary ammonium and piperidinium bases | |
DE2653477A1 (en) | SPIRO SQUARE CLAMP ON CYCLOPROPANE 1,2'-INDOLINE SQUARE CLAMP FOR -3'-ONE | |
CH631714A5 (en) | Process for preparing novel quaternary derivatives of sandwicin | |
DE1182237B (en) | Process for the preparation of 10- [4'-hydroxy-4'-hydroxyalkylpiperidinoalkyl] -phenthiazine derivatives | |
AT256106B (en) | Process for the preparation of new heterocyclic compounds and their salts | |
DE1618310C3 (en) | ||
DE2518516C3 (en) | 2- (3,45-trimethoxybenzyl) -3,4-dimethylpyridine | |
DE946145C (en) | Process for the preparation of alkyl or alkoxalkylaminobenzoic acid esters | |
DE1420954C (en) | Halogen-substituted 5-phenyl-2-aminooxazolone (4) derivatives and processes for their preparation | |
DE1445800C (en) | Process for the preparation of diben zoazepines | |
DE1470196C (en) | 1 Hydroxymethyl colchicindenvate and process for their preparation | |
DE1620556C (en) | 1 Cyclohexylbarbituric acid derivatives | |
DE1695695C3 (en) | Process for the preparation of 2-aminofuro square bracket to 2,3-square bracket to thiazoles | |
AT202130B (en) | Process for the preparation of new 2- (Δ <1 '> - cycloalkenyl) - or cycloalkyl-2-aminoalkyl-cycloalkanones and their salts | |
DE1032257B (en) | Process for the production of new hydantoins | |
DE1042593B (en) | Process for the preparation of the tropine ester of xanthene-9-carboxylic acid and its quaternary and bisquaternary salts | |
DE1062703B (en) | Process for the production of scopolin, its esters and ethers as well as their quaternary ammonium compounds | |
DE1246755B (en) | Process for the preparation of substituted coumarones | |
DE1470264B2 (en) | Process for the preparation of 1-phenyl-1 - square brackets on thienyl- (2) square brackets to -carbinols | |
DE1290542B (en) | Process for the preparation of new derivatives of primulic acid |